The effects of IL-6 on cell adhesion and E-cadherin expression in breast cancer

Cytokine

Volumn 10, Issue 9, 1998, Pages 720-728

  Ásgeirsson, Kristján Skúli ^a   Ólafsdóttir, Kristrún ^b   Jónasson, Jón Gunnlaugur ^b   Ógmundsdóttir, Helga M ^a  

^a ICELANDIC CANCER SOCIETY   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Breast cancer; Cell motility; E cadherin; IL 6; Metastasis

Indexed keywords

INTERLEUKIN 6; UVOMORULIN;

ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST EPITHELIUM; CANCER INHIBITION; CANCER SURVIVAL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN MCF 7; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032169130     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0349     Document Type: Article

References (45)

1. 1. Hirano T, Akira S, Taga T, Kishimoto T (1990) Biological and clinical effects of interleukin-6. Immunol Today 11:443-449.
2. 2. Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, Wallach D, Perricaudet M, Tiollais P, Revel M (1980) Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 77:7152-7156.
3. 3. Sehgal PB, May LT, Tamm I, Vilcek J (1987) Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical. Science 235:731-732.
4. 4. Kishimoto T (1989) The biology of interleukin-6. Blood 74:1-10.
5. 5. van Gameren MM, Willemse PH, Mulder NH, Limburg PC, Groen HJ, Vellenga E, de Vries EG (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 84:1434-1441.
6. 6. Krueger J, Ray A, Tamm I, Sehgal PB (1991) Expression and function of interleukin-6 in epithelial cells. J Cell Biochem 45:327-334.
7. 7. Zhang XG, Klein B, Bataille R (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 74:11-13.
8. 8. Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, Gadducci A, Perillo A, Facchini V, Peschle C, Mancuso S (1995) Prognostic significance of interleukin-6 serum levels in patients with ovarian cancer. Br J Cancer 71:354-356.
9. 9. Blay JY, Negrier S, Combaret V, Attali S, Goillet E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF, Philip T, Favrot M (1992) Serum level of interleukin 6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 52:3317-3322.
10. 10. Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, Peng FK, Chi CW (1996) Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 91:1417-1422.
11. 11. Mulé JJ, Custer MC, Travis WD, Rosenberg SA (1992) Cellular Mechanisms of the antitumor activity of recombinant IL-6 in mice. J Immunol 148:2622-2629.
12. 2. Proc Natl Acad Sci USA 85:8037-8041.
13. 13. Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB (1989) Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 170:1649-1669.
14. 14. Takeichi M (1990) Cadherins: A molecular family important in selective cell-cell adhesion. Annu Rev Biochem 59:237-252.
15. 15. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455.
16. 16. Behrens J, Marcel MM, Van Roy FM, Birchmeier W (1989) Dissecting tumor cell invasion: Epithelial cells aquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108:2435-2447.
17. 17. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185.
18. 18. Fish EM, Molitoris BA (1994) Alterations in epithelial polarity and the pathogenesis of disease states. N Engl J Med 330:1580-1588.
19. 19. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W (1991) E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337.
20. 20. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancer. Cancer Res 52:5104-5109.
21. 21. Lipponen P, Saarelainen E, Ji H, Aaltomaa S, Syrjanen K (1994) Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol 174:101-109.
22. 22. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ (1996) Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 105:394-402.
23. 23. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I (1993) E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53:1690-1695.
24. 24. Dorudi S, Sheffield J, Poulsom R, Northover JM, Hart IR (1993) E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142:981-986.
25. 25. Clarke R, Leonessa F, Brünner N, Thompson EW (1995) In vitro models of breast cancer. In Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast, J.B. Lippincott, Philadelphia, pp. 245-261.
26. 26. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD (1995) Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Molec Biol 52:459-467.
27. 27. Camby I, Kiss R (1993) In vitro estradiol-sensitivity characterization of the MCF-7, ZR-75-1, MDA-MB-231 and T47-D human breast neoplastic cell lines. Anticancer Res 13:2355-2360.
28. 28. Price JE, Polyzos A, Zhang RD, Daniels LM (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50:717-721.
29. 29. Tamm I, Cardinale I, Kikuchi T, Krueger JG (1994) E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells. Proc Natl Acad Sci USA 91:4338-4342.
30. 30. Tamm I, Kikuchi T, Cardinale I, Krueger JG (1994) Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells. Proc Natl Acad Sci USA 91:3329-3333.
31. 31. Tanner J, Tosato G (1991) Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice. J Clin Invest 88:239-247.
32. 32. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T, Kishimoto T (1989) Interleukin 6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinoma. FEBS Lett 250:607-610.
33. 33. Miles SA, Rezai AR, Salazar-Gonzalez JF, Vander Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, Martinez-Maza O (1990) AIDS-Kaposi's sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 40:4068-4072.
34. 34. Akira S, Kishimoto T (1992) The evidence for interleukin-6 as an autocrine growth factor in malignancy. Semin Cancer Biol 3:17-26.
35. 35. Chiu JJ, Sgagias MK, Cowan KH (1996) Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 2:215-221.
36. 36. Brynjarsson H, Guomundsdóttir I, Ögmundsdóttir HM (1994) Growth stimulation of breast carcinoma cells by lymphokines in relation to expression to MHC class I. Scand J Immunol 40:696.
37. 37. Shiozaki H, Oka H, Inoue M, Tamura S (1996) E-cadherin mediated adhesion system in cancer cells. Cancer (Suppl.) 77:1605-1613.
38. 38. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845-3852.
39. 39. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations througout its extracellular domain. Oncogene 13: 1919-1925.
40. 40. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, Birchmeier W (1993) Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120:757-766.
41. 41. Ziemiecki A, Harpur AG, Wilks AF (1994) JAK protein tyrosine kinases: Their role in cytokine signalling. Trends Cell Biol 4:207-212.
42. 42. Taylor-Papadimitriou J, Burchell J, Chang S, Bartek J, Gendler S, Durban EM (1987) Use of monoclonal antibodies to define the phenotype of cells cultured from the human mammary gland. In Enami J, Ham RG (eds) Growth and differentiation of mammary epithelial cells in culture, Japan Scientific Societies Press, Tokyo, pp. 29-37.
43. 43. Petersen OW, van Deurs B (1987) Preservation of defined phenotypic traits in short-term cultured human breast cancer derived epithelial cells. Cancer Res 47:856-866.
44. 44. Moll R, Mitze M, Frixen UH, Birchmeier W (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143:1731-1742.
45. 45. Elston CW (1987) Grading of invasive carcinoma of the breast. In Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast, Churchill Livingstone, New York, pp. 300-312.